Photo of Sanja Percac-Lima,  MD, DMD, PhD

Sanja Percac-Lima, MD, DMD, PhD

Massachusetts General Hospital

Massachusetts General Hospital

Sanja Percac-Lima, MD, DMD, PhD

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Associate Professor, Medicine, Harvard Medical School
  • Physician, Medicine, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

Dr. Sanja Percac-Lima is an Associate Professor of Medicine at Harvard Medical School and a primary care physician at Massachusetts General Hospital (MGH) Chelsea Community Health Center. The primary focus of her research and innovation is improving equity in cancer screening and care in low-income, ethnic and racial minorities. Since 2008, as Physician Leader for Cancer Outreach Programs at MGH Cancer Center, she is developing, overseeing and evaluating patient navigation (PN) programs to improve cancer care in underserved populations. In 2011, she received the Prevent Cancer Prevention Foundation Laurel for Innovative Programs for developing the Colorectal cancer screening PN program that eliminated disparities in CRC screening at MGH Chelsea Health Center. The National Cancer Institute recognizes this program as an evidence based program to improve CRC screening. With support from Susan G. Komen MA Affiliate, she designed the first breast cancer screening PN program for women refugees.To reach out to all underserved patients within MGH primary care network, she embedded patient navigation into the Partners TopCare population management system for comprehensive cancer screening. The results of randomized control trial of this large comprehensive cancer screening program were published in JAMA Internal Medicine. In 2013, she received CCCD Award for Primary Care Physicians from American Cancer Society enabling her to develop and evaluate the first lung cancer screening PN program for high-risk smokers at five MGH community health centers. The program nearly tripled the lung screening rates in this vulnerable population. Her most recent program is Merck/MGH Alliance PN to improve patient-centered care during cancer treatment for low-income and minority patients newly diagnosed with cancer.

Publications

Powered by Harvard Catalyst
  • Percac-Lima S, Ashburner JM, Rigotti NA, Park ER, Chang Y, Kuchukhidze S, Atlas SJ. Patient navigation for lung cancer screening among current smokers in community health centers a randomized controlled trial. Cancer Med 2018; 7:894-902. PubMed
  • Forcino RC, Barr PJ, O'Malley AJ, Arend R, Castaldo MG, Ozanne EM, Percac-Lima S, Stults CD, Tai-Seale M, Thompson R, Elwyn G. Using CollaboRATE, a brief patient-reported measure of shared decision making: Results from three clinical settings in the United States. Health Expect 2017. PubMed
  • Alam S, Elwyn G, Percac-Lima S, Grande S, Durand MA. Assessing the acceptability and feasibility of encounter decision aids for early stage breast cancer targeted at underserved patients. BMC Med Inform Decis Mak 2016; 16:147. PubMed
  • Morgan RJ, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht K, Chen LM, Copeland L, Crispens MA, DeRosa M, Dorigo O, Gershenson DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Percac-Lima S, Pineda M, Plaxe SC, Powell MA, Ratner E, Remmenga SW, Rose PG, Sabbatini P, Santoso JT, Werner TL, Burns J, Hughes M. Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016; 14:1134-63. PubMed
  • Percac-Lima S, Ashburner JM, Zai AH, Chang Y, Oo SA, Guimaraes E, Atlas SJ. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial. JAMA Intern Med 2016; 176:930-7. PubMed
  • Nipp RD, Lee H, Powell E, Birrer NE, Poles E, Finkelstein D, Winkfield K, Percac-Lima S, Chabner B, Moy B. Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program. Oncologist 2016; 21:467-74. PubMed
  • Percac-Lima S, Ashburner JM, Shepard JO, Lennes IT, Rimmelin DE, Atlas SJ. Timeliness of Recommended Follow-Up After an Abnormal Finding on Diagnostic Chest CT in Smokers at High Risk of Developing Lung Cancer. J Am Coll Radiol 2016. PubMed
  • Percac-Lima S, Singer DE, Cronin PR, Chang Y, Zai AH. Can Text Messages Improve Attendance to Primary Care Appointments in Underserved Populations? J Health Care Poor Underserved 2016; 27:1709-1725. PubMed
  • Berkowitz SA, Percac-Lima S, Ashburner JM, Chang Y, Zai AH, He W, Grant RW, Atlas SJ. Building Equity Improvement into Quality Improvement: Reducing Socioeconomic Disparities in Colorectal Cancer Screening as Part of Population Health Management. J Gen Intern Med 2015. PubMed
  • Percac-Lima S, Cronin PR, Ryan DP, Chabner BA, Daly EA, Kimball AB. Patient navigation based on predictive modeling decreases no-show rates in cancer care. Cancer 2015. PubMed
  • Percac-Lima S, Ashburner JM, McCarthy AM, Piawah S, Atlas SJ. Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women. J Womens Health (Larchmt) 2015; 24:138-43. PubMed
  • Percac-Lima S, L√≥pez L, Ashburner JM, Green AR, Atlas SJ. The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network. Cancer 2014. PubMed
  • Percac-Lima S, Ashburner JM, Bond B, Oo SA, Atlas SJ. Decreasing disparities in breast cancer screening in refugee women using culturally tailored patient navigation. J Gen Intern Med 2013; 28:1463-8. PubMed
  • Percac-Lima S, Benner CS, Lui R, Aldrich LS, Oo SA, Regan N, Chabner BA. The impact of a culturally tailored patient navigator program on cervical cancer prevention in Latina women. J Womens Health (Larchmt) 2013; 22:426-31. PubMed
  • Holt NE, Percac-Lima S, Kurlinski LA, Thomas JC, Landry PM, Campbell B, Latham N, Ni P, Jette A, Leveille SG, Bean JF. The Boston Rehabilitative Impairment Study of the Elderly: a description of methods. Arch Phys Med Rehabil 2013. PubMed
  • Percac-Lima S, Milosavljevic B, Oo SA, Marable D, Bond B. Patient navigation to improve breast cancer screening in Bosnian refugees and immigrants. J Immigr Minor Health 2012. PubMed
  • Saadi A, Bond B, Percac-Lima S. Perspectives on preventive health care and barriers to breast cancer screening among Iraqi women refugees. J Immigr Minor Health 2012. PubMed
  • Percac-Lima S, Aldrich LS, Gamba GB, Bearse AM, Atlas SJ. Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy. J Gen Intern Med 2010; 25:1198-204. PubMed
  • Donelan K, Mailhot JR, Dutwin D, Barnicle K, Oo SA, Hobrecker K, Percac-Lima S, Chabner BA. Patient Perspectives of Clinical Care and Patient Navigation in Follow-up of Abnormal Mammography. J Gen Intern Med 2010. PubMed
  • Percac-Lima S,Grant RW,Green AR,Ashburner JM,Gamba G,Oo S,Richter JM,Atlas SJ. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med 2008; 24:211-7. PubMed
  • Green AR, Peters-Lewis A, Percac-Lima S, Betancourt JR, Richter JM, Janairo MP, Gamba GB, Atlas SJ. Barriers to Screening Colonoscopy for Low-income Latino and White Patients in an Urban Community Health Center. J Gen Intern Med 2008; 23:834-40. PubMed
  • Saadi A, Bond BE, Percac-Lima S. Bosnian, Iraqi, and Somali Refugee Women Speak: A Comparative Qualitative Study of Refugee Health Beliefs on Preventive Health and Breast Cancer Screening. Womens Health Issues 2015; 25:501-8. PubMed
  • Atlas SJ, Zai AH, Ashburner JM, Chang Y, Percac-Lima S, Levy DE, Chueh HC, Grant RW. Non-visit-based cancer screening using a novel population management system. J Am Board Fam Med 2014; 27:474-85. PubMed
Hide